Literature DB >> 32172939

CFTR gene variants, epidemiology and molecular pathology.

C Bareil1, A Bergougnoux2.   

Abstract

Pathogenic variants of the CFTR gene are responsible for a broad phenotypic spectrum characterized by malfunction of some exocrine tissues, with an autosomal recessive mode of inheritance. More than 2,000 variants, distributed throughout the CFTR gene, have been identified, with different effects on the gene and protein expression and function. Genotype-phenotype correlation studies have associated severe variants with a typical multi-organ form of cystic fibrosis, while mild variants are involved in monosymptomatic or adult-onset diseases, called CFTR-related disorders. However, the interpretation of rare variants remains challenging. This review presents an overview of the epidemiology of CFTR variants worldwide and in France and describes the functional classification. Finally, some frequent cystic fibrosis-causing and mild CFTR variants are used as example to depict the molecular pathology of the CFTR locus. Finally, we give the recommendations concerning nomenclature and classification that are useful for appropriate genetic counseling.
© 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved. © 2020 Elsevier Masson SAS. Tous droits réservés.

Entities:  

Keywords:  CFTR; Functional classification; Mutational spectrum; Variant

Mesh:

Substances:

Year:  2020        PMID: 32172939     DOI: 10.1016/S0929-693X(20)30044-0

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  8 in total

Review 1.  Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives.

Authors:  Irene Brusa; Elvira Sondo; Federico Falchi; Nicoletta Pedemonte; Marinella Roberti; Andrea Cavalli
Journal:  J Med Chem       Date:  2022-04-04       Impact factor: 8.039

2.  Association between phenotypic and genotypic characteristics and disease severity in individuals with cystic fibrosis.

Authors:  Gabriella Vieira Carneiro; Fabiana Sodré de Oliveira; Leandro Alves Pereira; Érica Rodrigues Mariano de Almeida Rezende; Luciana Carneiro Pereira Gonçalves; Vivian Mara Gonçalves de Oliveira Azevedo
Journal:  Rev Paul Pediatr       Date:  2022-09-09

Review 3.  Molecular Diagnosis and Genetic Counseling of Cystic Fibrosis and Related Disorders: New Challenges.

Authors:  Thierry Bienvenu; Maureen Lopez; Emmanuelle Girodon
Journal:  Genes (Basel)       Date:  2020-06-04       Impact factor: 4.096

Review 4.  The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery.

Authors:  Virginie Scotet; Carine L'Hostis; Claude Férec
Journal:  Genes (Basel)       Date:  2020-05-26       Impact factor: 4.096

5.  Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.

Authors:  Anya T Joynt; Taylor A Evans; Matthew J Pellicore; Emily F Davis-Marcisak; Melis A Aksit; Alice C Eastman; Shivani U Patel; Kathleen C Paul; Derek L Osorio; Alyssa D Bowling; Calvin U Cotton; Karen S Raraigh; Natalie E West; Christian A Merlo; Garry R Cutting; Neeraj Sharma
Journal:  PLoS Genet       Date:  2020-10-21       Impact factor: 5.917

6.  Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells.

Authors:  Paolo Scudieri; Ilaria Musante; Arianna Venturini; Daniela Guidone; Michele Genovese; Federico Cresta; Emanuela Caci; Alessandro Palleschi; Marco Poeta; Francesca Santamaria; Fabiana Ciciriello; Vincenzina Lucidi; Luis J V Galietta
Journal:  Cells       Date:  2020-09-13       Impact factor: 6.600

Review 7.  Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases.

Authors:  María Magallón; Ana Esther Carrión; Lucía Bañuls; Daniel Pellicer; Silvia Castillo; Sergio Bondía; María Mercedes Navarro-García; Cruz González; Francisco Dasí
Journal:  J Clin Med       Date:  2021-03-18       Impact factor: 4.241

8.  2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.

Authors:  Mao Wang; Alex G Gauthier; Thomas P Kennedy; Haichao Wang; Uday Kiran Velagapudi; Tanaji T Talele; Mosi Lin; Jiaqi Wu; LeeAnne Daley; Xiaojing Yang; Vivek Patel; Sung Soo Mun; Charles R Ashby; Lin L Mantell
Journal:  Mol Med       Date:  2021-07-16       Impact factor: 6.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.